What does CUSIP 14888U101 represent in this 13F holders report?

CUSIP 14888U101 is the security identifier for CPRX - CATALYST PHARMACEUTICALS, INC. - Common Stock used to aggregate holder disclosures.

How many institutions held CPRX - CATALYST PHARMACEUTICALS, INC. - Common Stock in Q2 2020?

138 institutional investors reported CPRX - CATALYST PHARMACEUTICALS, INC. - Common Stock for Q2 2020. Use the holders table for investor-level position and value details.

CATALYST PHARMACEUTICALS, INC. - Common Stock (CPRX)

CUSIP: 14888U101

Q2 2020 13F Holders as of 30 Jun 2020

Type / Class: Equity / Common Stock
Shares outstanding: 123,180,519
Total 13F shares: 64,719,712
Share change: -1,082,278
Total reported value: $299,102,386
Put/Call ratio: 9.9%
Price per share: $4.62
Number of holders: 138
Value change: -$2,974,113
Number of buys: 63
Number of sells: 61

Quarterly Holders Quick Answers

What is CUSIP 14888U101?
CUSIP 14888U101 identifies CPRX - CATALYST PHARMACEUTICALS, INC. - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Related Filing Research

Latest 13F filings for newly reported positions.
Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
Latest 10-Q/10-K reports for financial context tied to this issuer.
Recent insider transactions for executive and insider activity.
SEC investors directory and top value investors for manager drilldown.
Back to full security ownership history.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q3 2020
Previous quarter: Q1 2020

Recent filing periods for CUSIP 14888U101:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of CPRX - CATALYST PHARMACEUTICALS, INC. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
BlackRock Finance, Inc.	13F	Company	6.9%	8,465,550	$32,593,000	—	31 Mar 2020	13F
STATE STREET CORP	13F	Company	6%	7,440,822	$28,647,000	—	31 Mar 2020	13F
ARMISTICE CAPITAL, LLC	13F	Company	4.4%	5,400,000	$20,790,000	—	31 Mar 2020	13F
VANGUARD GROUP INC	13F	Company	4.2%	5,144,116	$19,805,000	—	31 Mar 2020	13F
MANGROVE PARTNERS IM, LLC	13F	Company	3.5%	4,355,416	$16,768,000	—	31 Mar 2020	13F
MORGAN STANLEY	13F	Company	2.2%	2,712,529	$10,443,000	—	31 Mar 2020	13F
GOLDMAN SACHS GROUP INC	13F	Company	1.6%	1,964,464	$7,563,000	—	31 Mar 2020	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	1.3%	1,541,357	$5,934,000	—	31 Mar 2020	13F
PURA VIDA INVESTMENTS, LLC	13F	Company	1.2%	1,446,953	$5,571,000	—	31 Mar 2020	13F
SCHRODER INVESTMENT MANAGEMENT GROUP	13F	Company	1.1%	1,328,566	$5,208,000	—	31 Mar 2020	13F
NORTHERN TRUST CORP	13F	Company	1%	1,230,963	$4,739,000	—	31 Mar 2020	13F
AQR CAPITAL MANAGEMENT LLC	13F	Company	0.98%	1,212,449	$4,668,000	—	31 Mar 2020	13F
MARSHALL WACE, LLP	13F	Company	0.9%	1,105,426	$4,256,000	—	31 Mar 2020	13F
BAKER BROS. ADVISORS LP	13F	Company	0.86%	1,060,714	$4,084,000	—	31 Mar 2020	13F
Opaleye Management Inc.	13F	Company	0.85%	1,050,000	$4,043,000	—	31 Mar 2020	13F
PRUDENTIAL FINANCIAL INC	13F	Company	0.84%	1,029,468	$3,963,000	—	31 Mar 2020	13F
CITADEL ADVISORS LLC	13F	Company	0.71%	874,712	$3,367,000	—	31 Mar 2020	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.7%	864,859	$3,330,000	—	31 Mar 2020	13F
ACADIAN ASSET MANAGEMENT LLC	13F	Company	0.7%	864,147	$3,327,000	—	31 Mar 2020	13F
D. E. Shaw & Co., Inc.	13F	Company	0.68%	834,597	$3,214,000	—	31 Mar 2020	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	0.68%	833,001	$3,207,000	—	31 Mar 2020	13F
JPMORGAN CHASE & CO	13F	Company	0.64%	791,864	$3,048,000	—	31 Mar 2020	13F
RENAISSANCE TECHNOLOGIES LLC	13F	Company	0.6%	739,226	$2,846,000	—	31 Mar 2020	13F
ROYCE & ASSOCIATES LP	13F	Company	0.52%	643,991	$2,479,000	—	31 Mar 2020	13F
DIMENSIONAL FUND ADVISORS LP	13F	Company	0.44%	546,362	$2,103,000	—	31 Mar 2020	13F
GABLES CAPITAL MANAGEMENT INC.	13F	Company	0.42%	512,864	$1,979,000	—	31 Mar 2020	13F
DEUTSCHE BANK AG\	13F	Company	0.4%	487,307	$1,876,000	—	31 Mar 2020	13F
J. Goldman & Co LP	13F	Company	0.37%	454,773	$1,751,000	—	31 Mar 2020	13F
QS Investors, LLC	13F	Company	0.37%	450,182	$1,734,000	—	31 Mar 2020	13F
TWO SIGMA ADVISERS, LP	13F	Company	0.36%	441,192	$1,699,000	—	31 Mar 2020	13F
Bank of New York Mellon Corp	13F	Company	0.35%	427,802	$1,647,000	—	31 Mar 2020	13F
Nuveen Asset Management, LLC	13F	Company	0.32%	399,418	$1,538,000	—	31 Mar 2020	13F
Wealthspire Advisors, LLC	13F	Company	0.27%	337,770	$1,300,000	—	31 Mar 2020	13F
Brandywine Global Investment Management, LLC	13F	Company	0.27%	337,562	$1,300,000	—	31 Mar 2020	13F
PDT Partners, LLC	13F	Company	0.27%	327,000	$1,259,000	—	31 Mar 2020	13F
CADENCE CAPITAL MANAGEMENT LLC	13F	Company	0.26%	321,128	$1,236,000	—	31 Mar 2020	13F
Russell Investments Group, Ltd.	13F	Company	0.26%	319,985	$1,232,000	—	31 Mar 2020	13F
CREDIT SUISSE AG/	13F	Company	0.26%	319,960	$1,231,000	—	31 Mar 2020	13F
LOS ANGELES CAPITAL MANAGEMENT LLC	13F	Company	0.26%	315,005	$1,213,000	—	31 Mar 2020	13F
TANAKA CAPITAL MANAGEMENT INC	13F	Company	0.23%	277,774	$1,069,000	—	31 Mar 2020	13F
FEDERATED HERMES, INC.	13F	Company	0.21%	261,196	$1,005,000	—	31 Mar 2020	13F
BARCLAYS PLC	13F	Company	0.21%	254,683	$981,000	—	31 Mar 2020	13F
JACOBS LEVY EQUITY MANAGEMENT, INC	13F	Company	0.2%	248,416	$956,000	—	31 Mar 2020	13F
Squarepoint Ops LLC	13F	Company	0.2%	247,194	$952,000	—	31 Mar 2020	13F
Raymond James Financial Services Advisors, Inc.	13F	Company	0.19%	236,901	$912,000	—	31 Mar 2020	13F
Worth Venture Partners, LLC	13F	Company	0.19%	234,625	$903,000	—	31 Mar 2020	13F
WELLS FARGO & COMPANY/MN	13F	Company	0.18%	225,767	$869,000	—	31 Mar 2020	13F
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM	13F	Company	0.18%	225,229	$867,000	—	31 Mar 2020	13F
Capital Impact Advisors, LLC	13F	Company	0.16%	203,133	$782,000	—	31 Mar 2020	13F
GROUP ONE TRADING LLC	13F	Company	0.16%	201,698	$777,000	—	31 Mar 2020	13F

Institutional Holders of CATALYST PHARMACEUTICALS, INC. - Common Stock (CPRX) as of Q2 2020

As of 30 Jun 2020, CATALYST PHARMACEUTICALS, INC. - Common Stock (CPRX) was held by 138 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 64,719,712 shares. The largest 10 holders included BlackRock Inc., STATE STREET CORP, ARMISTICE CAPITAL, LLC, VANGUARD GROUP INC, MANGROVE PARTNERS, MORGAN STANLEY, GOLDMAN SACHS GROUP INC, SCHRODER INVESTMENT MANAGEMENT GROUP, GEODE CAPITAL MANAGEMENT, LLC, and PRUDENTIAL FINANCIAL INC. This page lists 138 institutional shareholders reporting positions in this security for the Q2 2020 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q2 2020 vs Q1 2020 Across Filers

Q1 2020 holders

128

Q2 2020 holders

138

Holder diff

Investor	Q1 2020 Shares	Q2 2020 Shares	Share Diff	Share Chg %	Q1 2020 Value $	Q2 2020 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.